Viridian Therapeutics Correlations

VRDN Stock

USD 13.62 0.12 0.87%

A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viridian Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viridian Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Viridian Therapeutics Correlation With Market

Good diversification

The correlation between Viridian Therapeutics and DJI is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Viridian Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viridian Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Viridian Stock, please use our How to Invest in Viridian Therapeutics guide.

Moving together with Viridian Stock

0.77	EQ	Equillium	Pair Corr
0.85	DMAC	DiaMedica Therapeutics Earnings Call This Week	Pair Corr
0.83	VANI	Vivani Medical	Pair Corr
0.85	DNLI	Denali Therapeutics Earnings Call Tomorrow	Pair Corr
0.76	DNTH	Dianthus Therapeutics Earnings Call This Week	Pair Corr
0.88	VCEL	Vericel Corp Ord Earnings Call This Week	Pair Corr
0.81	VCYT	Veracyte Earnings Call Tomorrow	Pair Corr
0.92	VERV	Verve Therapeutics	Pair Corr
0.95	VERA	Vera Therapeutics	Pair Corr
0.71	DRMA	Dermata Therapeutics Earnings Call This Week	Pair Corr
0.77	DRUG	Bright Minds Biosciences	Pair Corr
0.84	DRTS	Alpha Tau Medical	Pair Corr
0.64	DSGN	Design Therapeutics Earnings Call This Week	Pair Corr
0.77	VIGL	Vigil Neuroscience	Pair Corr
0.81	DWTX	Dogwood Therapeutics, Earnings Call This Week	Pair Corr
0.87	VKTX	Viking Therapeutics	Pair Corr
0.8	DYAI	Dyadic International	Pair Corr
0.84	VRAX	Virax Biolabs Group	Pair Corr
0.71	VRCA	Verrica Pharmaceuticals	Pair Corr
0.87	VTGN	VistaGen Therapeutics	Pair Corr
0.93	VTYX	Ventyx Biosciences	Pair Corr

Moving against Viridian Stock

0.4

SRZNW

Surrozen Warrant

Pair Corr

Related Correlations Analysis

	NUVL	DICE	ACLX	PCVX	CRNX	CYTK	GPCR	ICVX	PLRX	SNDX
NUVL		0.0	0.45	0.7	0.88	0.69	0.83	0.0	0.69	0.78	NUVL
DICE	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	DICE
ACLX	0.45	0.0		0.55	0.67	0.5	0.38	0.0	0.11	0.32	ACLX
PCVX	0.7	0.0	0.55		0.8	0.82	0.46	0.0	0.49	0.75	PCVX
CRNX	0.88	0.0	0.67	0.8		0.8	0.78	0.0	0.61	0.78	CRNX
CYTK	0.69	0.0	0.5	0.82	0.8		0.5	0.0	0.52	0.75	CYTK
GPCR	0.83	0.0	0.38	0.46	0.78	0.5		0.0	0.63	0.68	GPCR
ICVX	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	ICVX
PLRX	0.69	0.0	0.11	0.49	0.61	0.52	0.63	0.0		0.44	PLRX
SNDX	0.78	0.0	0.32	0.75	0.78	0.75	0.68	0.0	0.44		SNDX
	NUVL	DICE	ACLX	PCVX	CRNX	CYTK	GPCR	ICVX	PLRX	SNDX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CRNX	+ 0.88	NUVL
GPCR	+ 0.83	NUVL
CYTK	+ 0.82	PCVX
CRNX	+ 0.8	PCVX
CYTK	+ 0.8	CRNX
SNDX	+ 0.78	NUVL

High negative correlations

SNDX	- 0.0	ICVX
PLRX	- 0.0	ICVX
ICVX	- 0.0	GPCR
ICVX	- 0.0	CYTK
ICVX	- 0.0	CRNX
ICVX	- 0.0	PCVX

Risk-Adjusted Indicators

There is a big difference between Viridian Stock performing well and Viridian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viridian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NUVL	2.30	(0.13)	0.00	0.48	0.00	0.00	4.26	(4.19)	13.26
DICE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ACLX	2.70	0.05	0.05	(0.40)	3.36	(2.70)	5.59	(5.73)	17.88
PCVX	3.72	(1.10)	0.00	2.30	0.00	0.00	5.25	(8.96)	50.83
CRNX	2.57	(0.18)	0.00	1.20	0.00	0.00	4.42	(6.86)	16.44
CYTK	3.00	(0.29)	0.00	(1.05)	0.00	0.00	7.33	(7.39)	23.89
GPCR	4.38	0.13	0.04	0.50	5.52	(4.63)	9.70	(10.88)	27.23
ICVX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PLRX	6.87	(1.74)	0.00	3.38	0.00	0.00	10.38	(14.98)	80.84
SNDX	3.08	(0.02)	0.03	(0.02)	3.90	(3.19)	7.99	(6.75)	18.12

Viridian Therapeutics Corporate Management

Kyle Haraldsen	Chief Officer	Profile
Melissa Manno	Chief Officer	Profile
MBA MD	Chief Officer	Profile
Jonathan MBA	CEO, CoFounder	Profile
Shan Wu	Chief Officer	Profile
Vahe Bedian	CoFounder Scientist	Profile
Lara Meisner	Sr Counsel	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC